MOLECULAR GENETICS OF HUMAN X CHROMOSOME INACTIVATION
人类 X 染色体失活的分子遗传学
基本信息
- 批准号:2022439
- 负责人:
- 金额:$ 28.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-01-01 至 1999-11-30
- 项目状态:已结题
- 来源:
- 关键词:DNA methylation DNA replication RNase protection assay alleles cytogenetics developmental genetics early embryonic stage embryonic stem cell fluorescent in situ hybridization gene expression gene induction /repression gene mutation genetic regulatory element genetic transcription genetically modified animals human genetic material tag laboratory mouse molecular cloning molecular genetics northern blottings nucleic acid sequence polymerase chain reaction regulatory gene sex chromosomes transfection
项目摘要
X chromosome inactivation is the process whereby one of the two X
chromosomes in somatic cells of mammalian females is inactivated early
in embryogenesis, presumably as a means of dosage compensation between
females, with two X chromosomes, and males, with one. While the
essential features of X inactivation have been known for over 30 years,
the precise molecular, genetic, and developmental details of this lone-
range chromosomal control mechanism remain unclear. Over the past few
years, substantial progress has been made in the definition and
understanding of the various steps involved in X inactivation:
initiation early in development through the action of the X inactivation
center, promulgation of the inactivation signal and establishment of the
inactive state along the chromosome in a strictly cis-limited manner, and
maintenance of the various epigenetic states through subsequent cell
divisions. A strong candidate for a gene involved in X inactivation,
XIST, was described by us in 1991. Since then, significant genetic and
developmental evidence has been presented in both humans and mice that
supports a role for XIST in the initiation and perhaps establishment of
the X inactivation signal. These data provide a framework for further
experiments designed to test the hypothesis that the XIST gene, with its
regulatory sequences, both controls the initial choice of which X
chromosome to inactivate and subsequently establishes a context within
the nucleus to distinguish the active from the inactive X chromosome.
The experiments described in this application have three specific aims:
(1) to determine the nature of the X inactivation center and the role
of XIST in initiating X inactivation, by examining the effect(s) of
expressing the XIST gene in mouse embryonic stem cells and/or in
transgenic mice, by determining the effect(s) of a recently discovered
mutation in XIST on the initiation of X inactivation, and by
characterizing additional such mutations in families with multiple cases
of non-random X inactivation; (2) to determine a developmental context
for the establishment of X inactivation, by studying the expression of
genes subject to and escaping from X inactivation in mice early in
development at the time X inactivation occurs. This is in order to
determine whether escape from inactivation is a failure of initiation,
establishment, or maintenance of X inactivation; and (3) to examine the
chromosomal basis for X inactivation, by studying the distribution of
genes on the human and mouse X-chromosomes that are subject to or escape
from X inactivation and by using transgenic mice to specifically test the
hypothesis that X inactivation is determined at the level of chromosomal
domains rather than on an individual gene basis. The proposed
experiments should provide a definitive genetic and molecular test of the
hypothesis that the XIST gene is, in fact, part of the X inactivation
pathway, as well as provide insights into the chromosomal, developmental,
and molecular mechanisms by which cis-limited control of X-linked gene
expression is achieved.
X染色体失活是两个X染色体之一的过程
雌性哺乳动物体细胞中的染色体早期失活
在胚胎发生中,大概是作为剂量补偿的一种手段
女性有两条X染色体,男性有一条。 虽然
X 失活的基本特征已为人所知 30 多年,
这个孤独的精确的分子、遗传和发育细节
范围染色体控制机制仍不清楚。 过去几年
多年来,在定义和
了解 X 失活涉及的各个步骤:
通过 X 失活作用在发育早期启动
中心,发布灭活信号并建立
沿着染色体以严格顺式限制的方式处于非活性状态,并且
通过后续细胞维持各种表观遗传状态
部门。 参与 X 失活的基因的有力候选者,
XIST 是我们在 1991 年描述的。从那时起,显着的遗传和
人类和小鼠的发育证据均已提出
支持 XIST 在启动和可能建立中的作用
X失活信号。 这些数据为进一步
旨在检验 XIST 基因及其相关假设的实验
调控序列,都控制着 X 的初始选择
染色体失活并随后在其中建立上下文
细胞核以区分活性 X 染色体和非活性 X 染色体。
本申请中描述的实验具有三个具体目标:
(1)确定X失活中心的性质及作用
XIST 在启动 X 失活中的作用,通过检查
在小鼠胚胎干细胞和/或
转基因小鼠,通过确定最近发现的一种或多种效应
X 失活开始时 XIST 发生突变,并且通过
描述具有多个病例的家庭中其他此类突变的特征
非随机 X 失活; (2)确定发展背景
通过研究 X 失活的表达
小鼠早期遭受和逃避 X 失活的基因
X失活发生时的发育。 这是为了
确定逃避失活是否是启动失败,
X失活的建立或维持; (3) 检查
通过研究 X 失活的染色体基础
人类和小鼠 X 染色体上易受或逃避的基因
X 失活并使用转基因小鼠专门测试
假设 X 失活是在染色体水平上决定的
域而不是单个基因的基础上。 拟议的
实验应提供明确的遗传和分子测试
假设 XIST 基因实际上是 X 失活的一部分
途径,并提供对染色体、发育、
X连锁基因顺式限制控制的分子机制
表达就达到了。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Huntington F Willard其他文献
Huntington F Willard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Huntington F Willard', 18)}}的其他基金
High-performance Computing System for Bioinformatics
高性能生物信息计算系统
- 批准号:
7595665 - 财政年份:2009
- 资助金额:
$ 28.12万 - 项目类别:
Analysis of Human Centromeres using Novel Artificial Chromosome Vectors
使用新型人工染色体载体分析人类着丝粒
- 批准号:
7391601 - 财政年份:2006
- 资助金额:
$ 28.12万 - 项目类别:
Training in the Genome Sciences and the Hemoglobinopathies
基因组科学和血红蛋白病培训
- 批准号:
7196328 - 财政年份:2006
- 资助金额:
$ 28.12万 - 项目类别:
Analysis of Human Centromeres using Novel Artificial Chromosome Vectors
使用新型人工染色体载体分析人类着丝粒
- 批准号:
7599187 - 财政年份:2006
- 资助金额:
$ 28.12万 - 项目类别:
Training in the Genome Sciences and the Hemoglobinopathies
基因组科学和血红蛋白病培训
- 批准号:
7228255 - 财政年份:2006
- 资助金额:
$ 28.12万 - 项目类别:
Training in the Genome Sciences and the Hemoglobinopathies
基因组科学和血红蛋白病培训
- 批准号:
7099078 - 财政年份:2006
- 资助金额:
$ 28.12万 - 项目类别:
Training in the Genome Sciences and the Hemoglobinopathies
基因组科学和血红蛋白病培训
- 批准号:
7640611 - 财政年份:2006
- 资助金额:
$ 28.12万 - 项目类别:
Analysis of Human Centromeres using Novel Artificial Chromosome Vectors
使用新型人工染色体载体分析人类着丝粒
- 批准号:
7201561 - 财政年份:2006
- 资助金额:
$ 28.12万 - 项目类别:
Training in the Genome Sciences and the Hemoglobinopathies
基因组科学和血红蛋白病培训
- 批准号:
7502696 - 财政年份:2006
- 资助金额:
$ 28.12万 - 项目类别:
Training in the Genome Sciences and the Hemoglobinopathies
基因组科学和血红蛋白病培训
- 批准号:
7643451 - 财政年份:2006
- 资助金额:
$ 28.12万 - 项目类别:
相似国自然基金
Sin3复合体通过液-液相分离调控DNA复制的机制研究
- 批准号:32300562
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
酿酒酵母DNA复制所需还原物类型及其精准供给机制
- 批准号:32300436
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
EBNA1和RNA G-四链体的结构解析及其在鼻咽癌中调控EB病毒DNA复制的机制研究
- 批准号:32301012
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CST与DHX9相互作用重启停滞DNA复制参与PARP抑制剂在乳腺癌耐药中的机制研究
- 批准号:82303619
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
染色质解旋酶DNA结合蛋白2调控禽白血病病毒复制的分子机制研究
- 批准号:32302872
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目